1. Barratt-Boyes SM, Figdor CG. Current issues in delivering DCs for
immunotherapy. Cytotherapy, 2004. 6(2):
105-10.
2. Torensma R, Figdor CG. Differentiating stem cells mask their origins.
Stem Cells, 2004. 22(3): 250-2.
3. Lesterhuis WJ, de Vries IJ, Adema GJ, Punt CJ. Dendritic cell-based vaccines in cancer
immunotherapy: an update on clinical and immunological results.
Ann Oncol, 2004. 15 Suppl 4: iv145-51.
4. van Herpen CM, Looman M, Zonneveld M, Scharenborg N, de Wilde
PC, van de Locht L, Merkx MA, Adema GJ, de Mulder PH. Intratumoral administration of recombinant human
interleukin 12 in head and neck squamous cell carcinoma patients
elicits a T-helper 1 profile in the locoregional lymph nodes.
Clin Cancer Res, 2004. 10(8): 2626-35.
5. Koopman M, Cambi A, de Bakker BI, Joosten B, Figdor CG, van
Hulst NF, Garcia-Parajo MF. Near-field scanning optical microscopy in liquid
for high resolution single molecule detection on dendritic
cells. FEBS Lett, 2004. 573(1-3): 6-10.
6. Radstake TR, Blom AB, Sloetjes AW, van Gorselen EO, Pesman
GJ, Engelen L, Torensma R, van den Berg WB, Figdor CG, van Lent PL,
Adema GJ, Barrera P. Increased FcgammaRII expression and aberrant
tumour necrosis factor alpha production by mature dendritic cells
from patients with active rheumatoid arthritis. Ann
Rheum Dis, 2004. 63(12): 1556-63.
7. Chaput N, Schartz NE, Andre F, Taieb J, Novault S,
Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G,
Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin
E, Zitvogel L. Exosomes as potent cell-free peptide-based
vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1
lymphocytes leading to tumor rejection. J
Immunol, 2004. 172(4): 2137-46.
8. Bernsen MR, Diepstra JH, van Mil P, Punt CJ, Figdor CG, van
Muijen GN, Adema GJ, Ruiter DJ. Presence and localization of T-cell subsets in
relation to melanocyte differentiation antigen expression and
tumour regression as assessed by immunohistochemistry and molecular
analysis of microdissected T cells. J Pathol,
2004. 202(1): 70-9.
9. Cambi A, de Lange F, van Maarseveen NM, Nijhuis M, Joosten B,
van Dijk EM, de Bakker BI, Fransen JA, Bovee-Geurts PH, van Leeuwen
FN, Van Hulst NF, Figdor CG. Microdomains of the C-type lectin DC-SIGN are
portals for virus entry into dendritic cells. J Cell
Biol, 2004. 164(1): 145-55.
10. Radstake TR, van Lent PL, Pesman GJ, Blom AB, Sweep FG,
Ronnelid J, Adema GJ, Barrera P, van den Berg WB. High production of proinflammatory and Th1
cytokines by dendritic cells from patients with rheumatoid
arthritis, and down regulation upon FcgammaR triggering.
Ann Rheum Dis, 2004. 63(6): 696-702.
11. den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ,
Figdor CG, Ruers TJ, Adema GJ. In situ tumor ablation creates an antigen source
for the generation of antitumor immunity. Cancer
Res, 2004. 64(11): 4024-9.
12. Zimmerman AW, Nelissen JM, van Emst-de Vries SE, Willems PH,
de Lange F, Collard JG, van Leeuwen FN, Figdor CG. Cytoskeletal restraints regulate homotypic
ALCAM-mediated adhesion through PKCalpha independently of Rho-like
GTPases. J Cell Sci, 2004. 117(Pt 13):
2841-52.
13. van Spriel AB, Puls KL, Sofi M, Pouniotis D, Hochrein H,
Orinska Z, Knobeloch KP, Plebanski M, Wright MD. A regulatory role for CD37 in T cell
proliferation. J Immunol, 2004. 172(5):
2953-61.
14. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der
Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. Toll-like receptor 2 suppresses immunity against
Candida albicans through induction of IL-10 and regulatory T
cells. J Immunol, 2004. 172(6): 3712-8.
15. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way.
Nat Med, 2004. 10(5): 475-80.
16. Leitch J, Fraser K, Lane C, Putzu K, Adema GJ, Zhang QJ,
Jefferies WA, Bramson JL, Wan Y. CTL-dependent and -independent antitumor immunity
is determined by the tumor not the vaccine. J
Immunol, 2004. 172(9): 5200-5.
17. Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling
and malignant disease. Tissue Antigens, 2004.
64(5): 533-42.
18. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H,
Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W, Galy A,
Caignard A, Zitvogel L. NK cell activation by dendritic cells (DCs)
requires the formation of a synapse leading to IL-12 polarization
in DCs. Blood, 2004. 104(10): 3267-75.
19. Netea MG, Gijzen K, Coolen N, Verschueren I, Figdor C, Van
der Meer JW, Torensma R, Kullberg BJ. Human dendritic cells are less potent at killing
Candida albicans than both monocytes and macrophages.
Microbes Infect, 2004. 6(11): 985-9.
20. Wansink DG, Peters W, Schaafsma I, Sutmuller RP, Oerlemans
F, Adema GJ, Wieringa B, van der Zee CE, Hendriks W. Mild impairment of motor nerve repair in mice
lacking PTP-BL tyrosine phosphatase activity. Physiol
Genomics, 2004. 19(1): 50-60.